Your browser doesn't support javascript.
loading
Per- and polyfluoroalkyl substances exposure is associated with polycystic ovary syndrome risk among women attending a fertility clinic.
Zhang, Yu; Martin, Leah; Mustieles, Vicente; Ghaly, Mina; Archer, Madeleine; Sun, Yang; Torres, Nicole; Coburn-Sanderson, Ayanna; Souter, Irene; Petrozza, John C; Botelho, Julianne C; Calafat, Antonia M; Wang, Yi-Xin; Messerlian, Carmen.
Afiliação
  • Zhang Y; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: yuzhang@hsph.harvard.edu.
  • Martin L; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Mustieles V; Instituto de Investigación Biosanitaria Ibs GRANADA, Spain; University of Granada, Center for Biomedical Research (CIBM), Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Spain.
  • Ghaly M; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Archer M; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Sun Y; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Torres N; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Coburn-Sanderson A; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Souter I; Department of Obstetrics and Gynecology, Vincent Center for Reproductive Biology, Massachusetts General Hospital Fertility Center, Boston, MA, USA.
  • Petrozza JC; Department of Obstetrics and Gynecology, Vincent Center for Reproductive Biology, Massachusetts General Hospital Fertility Center, Boston, MA, USA.
  • Botelho JC; National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Calafat AM; National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Wang YX; Department of Environmental Health, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Messerlian C; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Obstetrics and Gynecology, Vincent Center for Reproductive Biology, Massachusetts General Hospital Fertility Center, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of
Sci Total Environ ; 950: 175313, 2024 Aug 06.
Article em En | MEDLINE | ID: mdl-39117221
ABSTRACT
Previous studies reported that exposures to per- and polyfluoroalkyl substances (PFAS), largely in higher exposed populations, were associated with elevated risk of polycystic ovary syndrome (PCOS). However, studies evaluating PCOS risk in populations with lower background exposures to PFAS are limited. This study aimed to examine the associations between serum PFAS concentrations and PCOS risk among women attending a U.S. academic fertility clinic during 2005-2019. A total of 502 females who sought fertility evaluation and assisted reproduction treatments were included. Nine PFAS were quantified in non-fasting serum samples collected at study entry. Diagnosis of PCOS was based on the Rotterdam criteria. We used logistic regression to examine the odds ratio (OR) of PCOS in relation to individual PFAS concentrations (continuous and by tertiles) and quantile g-computation (QGC) and Bayesian Kernel Machine Regression (BKMR) to examine the joint associations of PFAS mixture with PCOS. Most participants were White and had a graduate degree or higher. Per doubling of serum perfluorooctane sulfonate (PFOS) and perfluorohexane sulfonate (PFHxS) concentrations were associated with higher odds of PCOS [OR (95%CI) 1.70 (1.06, 2.81) and 1.45 (1.02, 2.08) for PFOS and PFHxS respectively]. There was a dose-response relationship of PFOS with PCOS risk (p of trend by PFOS tertiles = 0.07). Both QGC and BKMR identified PFOS as the most important contributor among the mixture to PCOS risk. No clear joint effects were found for other PFAS or PFAS mixtures on PCOS risk. Our findings are consistent with existing evidence in populations with higher background PFAS concentrations and highlight the adverse effects of PFAS exposure on reproductive health. Findings can inform public health measures and clinical care to protect populations vulnerable to PCOS, in part, due to environmental exposures.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article